SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,394.83 391.01
( 0.53%)

Global Indices

Nasdaq

52,102.03 -340.17
(-0.65%)

Dow Jones

7,605.54 -35.44
(-0.46%)

Hang Seng

63,783.20 299.10
(0.47%)

Nikkei 225

10,654.59 -42.98
(-0.40%)

Forex

USD-INR

95.28 -0.19
(-0.20%)

EUR-INR

110.09 -0.64
(-0.57%)

GBP-INR

128.59 -0.52
(-0.40%)

JPY-INR

0.62 0.00
(-0.70%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

93.2373503

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

138.28

440277.97

EPS(TTM)

Face Value()

Div & Yield %

13.27

0.87

Back

KSB consolidated net profit declines 22.87% in the March 2026 quarter

Apr 30,2026

Net profit of KSB declined 22.87% to Rs 39.80 crore in the quarter ended March 2026 as against Rs 51.60 crore during the previous quarter ended March 2025. Sales rose 0.99% to Rs 601.30 crore in the quarter ended March 2026 as against Rs 595.40 crore during the previous quarter ended March 2025.

Particulars	Quarter Ended
	Mar. 2026	Mar. 2025	% Var.
Sales	601.30	595.40	1
OPM %	8.45	11.37	-
PBDT	67.80	82.90	-18
PBT	53.30	69.00	-23
NP	39.80	51.60	-23

74,394.83 391.01 ( 0.53%)

52,102.03 -340.17 (-0.65%)

7,605.54 -35.44 (-0.46%)

63,783.20 299.10 (0.47%)

10,654.59 -42.98 (-0.40%)

95.28 -0.19 (-0.20%)

110.09 -0.64 (-0.57%)

128.59 -0.52 (-0.40%)

0.62 0.00 (-0.70%)